The scaffolding protein, hematopoietic PBX-interacting protein (HPIP/PBXIP1), regulates cell migration necessary for cancer cell dissemination. However, the mechanism that governs this process remains unknown. We show here that HPIP expression is associated with stages of breast cancer where cell dissemination results in poor patient outcome. Our investigation finds a novel association of HPIP with focal adhesion kinase (FAK) regulating FA dynamics. Interestingly, this interaction that led to activation of FAK protein was mediated by the C-terminal domain of HPIP and not the typical integrin-binding motif. Further, short hairpin RNA-mediated knockdown of FAK expression significantly reduced HPIP-induced cell migration indicating participation of FAK pathway. Live-cell time-lapse imaging and biochemical analysis further established the role of HPIP in microtubule-induced FA disassembly. We also found that HPIP-mediated MAPK activation led to phosphorylation and subsequent activation of calpain2, and the activated calpain2 in turn proteolyses FA protein, talin. Interestingly, HPIP is also proteolysed by calpain2 in breast cancer cells. The proteolysis of HPIP and talin by calpain2, and the activation of calapin2 by HPIP-mediated MAPK phosphorylation, is a novel regulatory axis to modulate the cell migration signal. Together, we have determined HPIP as a novel activator of FAK and a new substrate of calpain2. These molecular interactions between HPIP and FAK, and HPIP and calpain2 regulate cell adhesion and migration through modulation of FA dynamics.
INTRODUCTION
Progression of epithelial cancer involves complex coordinated processes of highly regulated molecular events such as loss of cell adhesion, cell-cell and cell-extracellular matrix interactions resulting in cell migration and invasion. 1, 2 These processes are to a major extent regulated by integrins and proteins associated with focal adhesion (FA) formation like FA kinase (FAK), paxillin, talin and others. 3 Cells move by applying traction forces against the substratum at focal contacts, besides these FAs also act as localized dynamic signaling centers that regulate cell migration. Such dynamic signaling centers involve FA turnover, leading edge protrusion, tail retraction and detachment. 4, 5 Importantly, coordination between actin cytoskeleton and microtubules is essential for efficient cell adhesion and migration. 6, 7 FAK is an essential regulator of cell migration as cells deficient in FAK showed poor cell migration and reintroduction of FAK into such cells restored cell migration. 8, 9 Overexpression and increased activity of FAK are found in several types of metastatic cancers. [10] [11] [12] [13] On localization to FAs, FAK activates itself by autophosphorylation at tyrosine 397. 14, 15 Phosphorylation at this site is important for controlling of FA turnover. 16 Recent report suggests that FAK phosphorylation at Y397 but not kinase domain is important for cell migration. 17 FAK appears to control FA turnover by modulating the activity of MAPK-calpain2 signaling pathway and is also a substrate of calpain2. 18 Although actin cytoskeleton and FAK have major roles in FA formation and maturation, growing body of evidence suggests that highly polarized activity of cell migration is brought about by microtubules. 19 Cells treated with microtubule poison drugs such as nocadazole interfere with cell migration by affecting the FA disassembly and cell migration in a FAK-dependent manner. 20 Furthermore, microtubule motor protein, kinesin-1, has been implicated in regulating microtubule-induced FA disassembly. 21 However, to date, only few reports are available to suggest the role of microtubule-binding proteins in FA turnover. Here we suggest a role for hematopoietic PBX-interacting protein (HPIP), also known as pre B-cell leukemia homeobox-interacting protein (PBXIP1), a microtubule-binding protein, in FA turnover and cell migration.
HPIP was initially identified as a PBX1-interacting protein that regulates PBX1-mediated transcription functions and later its role in hematopoiesis has been determined. 22, 23 We previously reported that HPIP interacts with microtubules and has a role in estrogen receptor signaling in cancer cells. 24 Recent studies revealed that HPIP is involved in proliferation, migration and anchorage-independent growth of breast cancer cells by activating the PI3K/AKT and Src/MAP kinase pathways. 24, 25 However, the precise mechanism of HPIP-mediated cell migration remains to be determined. Here we report that HPIP directly interacts and activates FAK by increasing FAK phosphorylation at Y397, which is important for HPIP-mediated cell migration. Further, we also show that HPIP promotes FA disassembly though MAPK-mediated calpain2 activation to ensure talin proteolysis that leads to FA turnover and thus cell migration.
RESULTS
HPIP is overexpressed in human breast infiltrative ductal carcinoma Previous demonstration of HPIP influencing migratory properties in breast cancer cell lines led to the hypothesis that HPIP may have a role during breast tumor progression to invasive stages in situ. 24 To test this hypothesis, we first analyzed the expression levels of HPIP in eight matched sets of primary mammary carcinoma vs surrounding healthy breast tissue by western blot analysis. As shown in Figure 1a , 87.5% of mammary carcinoma had elevated expression of HPIP compared with their normal counterparts. We further analyzed primary infiltrative breast tumors by immunohistochemistry. In support of our hypothesis, we noted 100% (32/32 cases vs 5/15 healthy primary tissues) of the infiltrative ductal carcinoma tissue expressing either very high (78%, 25/32) to moderately high (22%, 7/32) levels of HPIP (Figure 1b and c). Both in the normal tissues as well as in the tumors, HPIP expression was confined to cytoplasm, whereas no expression was observed in the nucleus. Further analysis of HPIP expression in 53 primary breast tumors from public cancer transcriptome database 26 also showed a higher expression of HPIP in infiltrative ductal carcinoma compared with non-tumor tissues ( Figure 1d ). Consistent with this data set, four other cancer data sets also showed similar results of HPIP expression in infiltrative ductal carcinoma as compared with non-tumor tissues ( Supplementary Figure 1) . To understand the clinical relevance of this observation, we performed Kaplan-Meier analysis 27 on breast cancer patients with molecular subtype defined as basal-like breast cancers that are highly invasive. We observed a significantly poor overall survival (P = 0.041) in breast cancer patients with elevated levels of HPIP in cancerous tissue compared with normal controls (Figure 1e ). Together, these results strongly support that elevated HPIP expression estimates poor patient survival and is positively correlated with invasive stages of cancer progression.
HPIP regulates cell migration by modulating cell adhesion behavior
Previously, the link between HPIP and cell migration has been reported involving estrogen signaling in breast cancer cell line, MCF7. 24 To confirm the functional link between cell migration and HPIP expression, we sought to determine the effect of HPIP knockdown on cell migration in MDA-MB231 cells, an estrogen receptor-negative invasive breast cancer cell line. To address this issue, we first generated MDA-MB231 cell lines that stably express control sh (scrambled short hairpin RNA (shRNA)), HPIP sh1 or HPIP sh2. Interestingly, HPIP knockdown clones showed tightly packed colonies compared with control cells that showed characteristic mesenchymal-like (spindle shape) appearance, suggesting possible changes in migratory function as a consequence of alterations in morphological features (Figures 2a and b) . Indeed, we observed a reduction in migration of HPIP knockdown cells as compared with control cells (Figure 2c ; Supplementary  Figure 2 ). However, forced overexpression of T7-HPIP in cells in which HPIP had been knocked down by HPIP sh1 restored cell migration (Figures 2b and c; Supplementary Figure 2 ). Cell adhesion assay performed on fibronectin-coated plates additionally showed that significantly increased proportion of HPIP knockdown cells adhered to the surface compared with control cells (Figure 2d ). However, increased cell adhesion observed in cells that had been knocked down by HPIP sh1 was rescued following overexpression of T7-HPIP ( Figure 2d ). These results indicate that HPIP is a regulator of breast cancer cell migration and it may partly involve in molecular mechanisms that suppress cell adhesion.
HPIP is a component of FAs and activates FAK Previously we have reported that HPIP functions as an adaptor/scaffold with multiple domains that facilitate to associate with various signaling proteins including microtubules. 24 To investigate the molecular players involved in HPIP-dependent cancer cell migration, we first asked whether HPIP was localized in plasma membrane regions and, if so, whether they were colocalized with key cell adhesion molecules. Preliminary analysis with MDA-MB231 cells suggested that HPIP was expressed in cell surface in a punctuate manner in regions that resembled FA sites and colocalized with vinculin, paxillin, zyxin or FAK ( Figure 3a) .
One of the hallmark events in cell adhesion is the activation of FA proteins through tyrosine phosphorylation. 28 Given the observation that HPIP is colocalized with FA proteins, we asked whether HPIP regulation of cell adhesion and migration involves tyrosine phosphorylation of these proteins. As shown in Figure 3b , an increased tyrosine phosphorylation of proteins ranging from 80 to 200 kDa (indicated by arrows) detected by panphosphotyrosine antibody is observed in HPIP-overexpressing cells compared with control cells. Activation of FAK by tyrosine (at position Y397) phosphorylation is an essential feature in various invasive and metastatic tumors. 12, 13 Therefore, we next analyzed the effect of HPIP expression on FAK activation. As shown in Figure 3c , ectopic expression of HPIP increased FAK phosphorylation at Y397 in MCF7 cell lines. Conversely, HPIP knockdown in MDA-MB231 cells reduced FAK Y397 phosphorylation indicating that HPIP regulates FAK phosphorylation, and therefore HPIPmediated cell migration may be dependent on FAK activation ( Figure 3d ).
Previous studies have shown that RGD domain activates the FAK through integrin signaling pathway. 15 Because HPIP contains a RGD domain at position 421-423, we verified its role on FAK activation (Supplementary Figure 3A ). As shown in Supplementary Figure 3B , mutation of RGD domain did not affect FAK activation by HPIP. Similarly, mouse HPIP, which contains RGA in place of RGD found in human HPIP, also activated FAK in MCF7 cells (Supplementary Figure 3C ). These results suggest that HPIPmediated activation of FAK in cancer cells is not dependent on its RGD domain.
HPIP activates FAK through its direct interaction with kinase domain
To test whether FAK activation by HPIP was a direct consequence of interaction of HPIP with FAK, we performed coimmunoprecipitation (Co-IP) using MDA-MB231 cell lysate. In Figure 4a , we show that HPIP was able to co-immunoprecipitate with FAK in these cells. Next we mapped the domains involved in the interaction between HPIP and FAK. As shown in Figure 4b , none of the HPIP deletion mutants (C-terminus) showed interaction with FAK, except full-length HPIP (1-731 amino acids). Conversely, Co-IP using green fluorescent protein (GFP) antibody (GFP-fusion FAK domains) demonstrated the involvement of kinase domain (KD) of FAK in binding to HPIP (Figure 4c ). Consistent with the above results, HPIP deletion mutants lost their ability to activate FAK, except full-length HPIP (Figure 4d ). Immunofluorescence analysis further supported that HPIP deletion mutants were unable to colocalize with FAK ( Supplementary  Figure 4 ). Together, these results suggest that C-terminal region spanning 583-731 amino acid region of HPIP is involved in interaction with kinase domain of FAK and is therefore important for FAK activation.
Accumulating evidence supports that FAK is a critical regulator of cell migration as enhanced FAK signaling promotes cell motility, whereas inhibition of FAK signaling impairs cell migration. 29 We hypothesized that HPIP-mediated cell migration requires FAK. To test this hypothesis, we measured cell migration in HPIP stably expressing MDA-MB231 cells under FAK knockdown conditions. As shown in Figures 4e and f, overexpression of T7-HPIP enhanced cell migration in MDA-MB231 cells compared with control cells; however, FAK knockdown reduced HPIP-induced cell migration suggesting that HPIP-mediated cell migration requires FAK.
Loss of HPIP results in defective FA turnover
To explore the possible mechanisms that underlie HPIP-induced FAK-mediated cell migration, we first determined the FA turnover in MDA-MD231 cells. As shown in Figure 5a , HPIP knockdown had little or no effects on the number of FAs, but these cells showed larger FAs compared with control cells (Figure 5b ). Similar observations were also made in MCF7 cells ( Figure 5c ). As large Survival Probability FAs at the cell periphery indicate defects in FA dynamics, 8, 30 we monitored FA turnover using high-resolution live-cell time-lapse video microscopy following cotransfection of MCF7 cells with either control sh or HPIP sh1 and DsRed-zyxin. A movie of the FA dynamics measured using DsRed-zyxin as a tracking molecule shows the assembly and disassembly of FAs (Figure 5c ; Supplementary Movies 1 and 2). Live fluorescence imaging demonstrated that zyxin-containing adhesions in HPIP knockdown cells were extended in duration by 20 min compared with control cells (control sh, 20 min, ± 3.823 vs HPIP sh, 40 min, ± 4.661; Figure 5d ). From plots of DsRed-zyxin fluorescence intensities over time (Supplementary Figure 5 ), we generated rate constants for net disassembly rates. As shown in Figure 5e , FA disassembly rate was significantly reduced in HPIP knockdown cells compared with control cells. Similar observations were made in MDA-MB231 cells (Supplementary Figure 6 ; Supplementary Movies 3 and 4). To further confirm whether HPIP-induced FA disassembly is dependent on FAK, we monitored the FA disassembly time in MCF7 cells transfected with either control vector or Flag-HPIP along with DsRed-Zyxin and were treated with F14, a FAK-specific inhibitor. As shown in Figure 5f , overexpression of Flag-HPIP reduced the disassembly time as compared with control cells; however, FAK inhibition by F14 significantly reduced the Flag-HPIP effects on FA disassembly (Supplementary Movies 5-8; Supplementary Figure 7 ). These data provide the first line of evidence that dynamics of FAs is partly controlled by HPIP through FAK, suggesting that this mechanism may have a role in HPIP-dependent cell migration.
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HPIP modulates microtubule-dependent FA disassembly As HPIP is a microtubule-binding protein, 24 and microtubule dynamics together with FAK activation are critical for FA disassembly, 20 here we speculated the role for HPIP in microtubule-dependent FA dynamics. As previously reported, serum-starved cells had relatively few FAs (~6% of cells have more than five FAs; Figure 6a ). 31 In HPIP knockdown cells, we observed a marked increase in the number of FAs present as compared with control cells (Figure 6a ), indicating a markedly reduced FA disassembly in HPIP knockdown cells. Next we examined whether HPIP promotes microtubule-dependent FA disassembly by microtubule regrowth assay in MDA-MD231 cells. Following nocodazole treatment, both control and HPIP knockdown cells accumulated FAs to a similar degree ( Figure 6b ). In contrast, following nocodazole washout and 30 min of microtubule regrowth, the number of cells containing FAs (45) was significantly reduced (from~70 to 22%,~3.1 fold) compared with HPIP knockdown cells (~65 to 40%,~1.6 fold; Figure 6b ), indicating that HPIP may control microtubule-dependent FA disassembly.
HPIP activates calpain2 through MAPK-mediated phosphorylation and is a substrate of calpain2 Calpain proteases have a crucial role in cell migration as they regulate FA disassembly by targeted cleavage of several FA proteins, including talin. 32, 33 Further, it has been reported that calpain2 phosphorylation by MAPK is required for its activation. 34 We have previously shown that HPIP activates MAPK in breast cancer cells. 24 On the basis of these findings, we hypothesized that HPIP-mediated MAPK activation may also impact on calpain2 phosphorylation and its activation. Consistent with this notion, our in vivo phosphorylation assay showed decreased calpain2 phosphorylation on HPIP knockdown (Figure 7a ). As shown in Figure 7b , MAPK activation is decreased on HPIP knockdown in MCF7 cells and as a result reduced talin proteolysis. Conversely, HPIP overexpression in MDA-MB231 cells enhanced talin proteolysis compared with control cells (Figure 7c ). Together, these For time-lapse FA disassembly assay, four to five cells were analyzed as described previously. 42 The results were expressed as means ± s.d., and differences between groups were analyzed by one-way analysis of variance.
results suggest that HPIP assists in calpain2-mediated talin proteolysis partly by calpain2 activation through MAPK signaling.
Interestingly, when cells were treated with calpain2 inhibitor ALLN, we noticed strikingly increased HPIP levels in MDA-MB231 cells (Figure 7d ). Consistent with previously reported cell lines, ALLN also inhibited calpain2-mediated FAK proteolysis and decreased the cell migration capacity of MDA-MB231 cells ( Supplementary Figure 8) . Further, Co-IP analysis showed that HPIP interacts with calpain2 (Figures 7e and f) , indicating that HPIP could be a potential substrate for this protease. To check this possibility, we performed an in vitro calpain2 proteolysis assay using recombinant calpain2 as an enzyme and immunoprecipitated GFP-HPIP (N-terminal tag) from HEK293T cell lysate as a substrate. As shown in Figure 7g (ponceau blot), calpain2 is capable of cleaving HPIP in the presence of 1 mM CaCl 2 , thereby releasing a protein band at~80 kDa (fourth lane, left). Immunoblot probing with HPIP antibody (the antigenic epitope is located in HPIP between 18 and 141 aa) did not detect HPIP (lane 4; middle), however, probing with anti-GFP detected~45 kDa protein band/s (molecular weight of GFP, 27 kDa plus N-terminal HPIP,~18 kDa; right). Consistent with these results, bacterial-purified GST-HPIP was also proteolysed by calpain2 ( Supplementary Figure 9) indicating that calpain2-binding site in HPIP is located at the N-terminus of the protein. Together, these results suggest that HPIP is a substrate of calpain2 in cancer cells.
DISCUSSION
Our investigation of the role of scaffold-protein HPIP has identified a mechanism by which it regulates cancer cell adhesion and migration. HPIP has been previously described to modulate cancer cell invasion by increasing cell migration in laboratory models. 24, 35 Previously, it was not clear whether HPIP levels could affect cancer progression in primary tumors. Here we show that elevated HPIP levels in primary breast cancers were significantly associated with poor patient survival. We also report a possible novel mechanism through which HPIP regulates cancer cell migration. We established cell lines that altered their migratory behavior in response to HPIP overexpression or knockdown. Using these cells, we identified the following key regulatory mechanisms: (1) HPIP is recruited to FA sites where it regulates FA turnover and migration. proteolysis (a novel substrate for calpain2) and thereby inhibition of FAK activation and desensitizing FA disassembly signal.
FAs regulate cell migration through their dynamic assembly and disassembly. 36, 37 Particularly, the activation of FAK is crucial for cell adhesion and migration. 29 FAK Y397 phosphorylation has been identified previously as a marker of FA signal activation. 14, 15 We and others have showed that cellular levels of HPIP are able to modulate cancer progression by influencing cancer cell migration. 24, 35 Here we clearly demonstrate that HPIP is recruited to FA sites and activates FAK. FAK phosphorylation at Y397 is a prerequisite for its activation as the inhibitor loop that formed through the interaction between FERM domain and kinase domain is disrupted. 38 It is interesting to note that HPIP may promote FAK activation as it binds to kinase domain so its autoinhibition through FERM domain will be suppressed. Recently, it has been reported that FAK phosphorylation at Y397 rather than the kinase activity of FAK is an important event in cell migration. 17 Therefore, FAK activation by HPIP may be an important step in HPIP-mediated cell migration.
FAs regulate cell migration through a dynamic process that involves disassembly of the macromolecules. Several disassembly factors and mechanisms have been proposed to explain how the FA disassembly is mediated. For instance, ZF21 regulates cell migration by modulating FAK Y397 phosphorylation, 39 whereas G2 and S phase-expressed-1 protein (GTSE1), a microtubule TIP-end-binding protein, regulates cell migration by modulating FA disassembly in an EB1-, another microtubule TIP-end-binding protein, dependent manner. 31 Similarly, ACF7, actin and microtubule-binding protein, has been shown to have a role in FA disassembly. 30 Interestingly, HPIP is also a microtubule-binding protein that directly interacts and activates FAK to modulate the microtubule-induced FA disassembly and cell migration. Further, in vitro microtubule polymerization assay indicated that HPIP promotes tubulin polymerization (data not shown). Together, these data suggest that the HPIP-mediated FA disassembly could be partly through the activation of FAK and also the modulation of microtubule dynamics.
Another intriguing mechanism for HPIP-mediated cell migration here we show is HPIP-mediated calpain2 activation through MAPK pathway. Because MAPK phosphorylation of calpain2 leads to its activation, 34 and we and others have shown the activation of MAPK by HPIP, 24, 25 we observed decreased calpian2 phosphorylation and talin proteolysis on HPIP knockdown, implying that calpain2 activation through MAPK and subsequent talin proteolysis is partly dependent on HPIP. Several proteins that participate in FA disassembly including FAK, paxillin and spectrin have been identified as calpain2 substrates and resistant mutants of these substrates failed to regulate adhesion dynamics. 40, 41 Interestingly, we also found that HPIP is a new substrate of calpain2. HPIP proteolysis by calpain2 provides a negative feedback mechanism to desensitize the cell migration signal (Figure 7h ). Further investigations are under way in our laboratory to identify the calpain2 cleavage site in HPIP. Future studies should envisage on the additional mechanisms and signaling proteins through which HPIP mediates FA turnover and cell migration.
MATERIALS AND METHODS
Cell culture MDA-MB231, MCF7 and HEK293T cells were grown at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. Stable knockdown of HPIP in either MDA-MB231 or MCF7 cells was carried out as described previously. 23, 24 Plasmids and site-directed mutagenesis pcDNA-HPIP, pEGFP-HPIP and pMNDUS-HPIP were made as previously described. [22] [23] [24] pCMV-HPIP shRNAs and control shRNA plasmids were purchased from OriGene, Rockville, MD, USA. HPIP shRNA1: 5ʹ-AAGG CTGAGCACTGGAAACATAAGAAGGA-3ʹ; HPIP shRNA2: 5ʹ-CTGCTGGACAAG CTGGCCAAGGAGAACCA-3ʹ. Various C-terminal deletion mutants of HPIP were generated by PCR amplification using pcDNA-HPIP as template with a common forward primer (fp) and three different reverse primers (rp): fp: 5ʹ-GCCGGGATCCATGGCCTCCTGCCCAGA-3ʹ (BamHI); rp for HPIP(1-582): 5ʹ-GCAGCCCTCGAGTGCCCGGTACTT-3ʹ (XhoI), for HPIP(1-488): 5ʹ-CTCAGC CTCGAGGTCTCTCTGCCA-3ʹ (XhoI) and for HPIP (1-327): 5ʹ-GAGCCCG CTCGAGGGCTTCGCCCT-3ʹ (XhoI). Underlined are the restriction enzymes sites used for subcloning into pcDNA3.1 vector. Similarly, FAK deletion mutants were generated by PCR using pCMV-HA-FAK as template with the following specific primers: FERM domain, fp: 5ʹ-ATGCGTCGACTATGGCA GCTGCTTACCT-3ʹ (SalI) and rp: 5ʹ-ATGCGGTACCTCAAATCTCAGCATAATC ATC-3ʹ (KpnI); kinase domain (KD), fp: 5ʹ-ATGCGTCGACTATAGATGAAGAA GATACT-3ʹ (SalI) and rp: 5ʹ-ATGCGGTACCTCAGGGGTCATAGGCCCAGC-3ʹ (KpnI); and FAT domain, fp: 5ʹ-ATGCGTCGACTAGCAGGCGGCCCAGGTTT-3ʹ (SalI) and rp: 5ʹ-ATGCGGTACCTCAGTGTGGTCTCGTCTG-3ʹ (KpnI). The PCRamplified fragments were ligated to pEGFP-C1 vector. RGD mutants of HPIP were generated using pcDNA-HPIP as template through PCR amplification by replacing glycine (G) at position 422 with an alanine (A) using the following primer pairs: fp: 5ʹ-GCCAGCCGCGCGGACCCAGCTCAT-3ʹ and rp: 5ʹ-ATGAGCTGGGTCCGCGCGGCTGGC-3ʹ. HPIP-RGE mutant was generated by replacing aspartic acid (D) at position 423 with glutamic acid (E) using following specific primer pairs: fp: 5ʹ-AGCCGCGGGGAACCAG CTCATGCT-3ʹ and rp: 5ʹ-AGCATGAGCTGGTTCCCCGCGGCT-3ʹ. The amplified plasmids were digested with DpnI enzyme followed by transformation into Escherichia coli DH5α cells and all clones were confirmed by DNA sequencing.
Western blot and Co-IP
Cells were lysed in RIPA lysis buffer (50 mM Tris-Cl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM PMSF and 1 × protease inhibitor cocktail) and subjected to SDS-PAGE followed by western blot using following protein-specific antibodies: anti-HPIP, anti-vinculin, anti-βactin, anti-β-tubulin (Sigma Aldrich, St Louis, MO, USA), anti-phospho-FAK Y397, anti-FAK, anti-talin, anti-calpain2 (Santa Cruz Biotechnology, Dallas, TX, USA), anti-phospho-tyrosine (pTyr-100), anti-GAPDH (Cell Signaling Technology, Danvers, MA, USA) and anti-T7 antibody (Novus Biologicals, Littleton, CO, USA). When necessary, cells were treated with ALLN, calpain2 inhibitor (20 μM), for 18 h and cell lysates were subjected to western blot. For Co-IP, cells were lysed in NP-40 lysis buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 10% glycerol, 1% Nonidet P-40, 2 mM EDTA and 1 × protease inhibitor cocktail). To study the interaction between FAK and HPIP by Co-IP, we lysed the cells in Triton X-100 lysis buffer (20 mM Tris pH 8.0, 137 mM NaCl, 10% glycerol, 0.1% Triton X-100, 2 mM EDTA and 1 × protease inhibitor cocktail). Immunoprecipitation with the indicated antibodies were carried out overnight at 4°C followed by incubation with agarose A/G beads for 1 h. After thorough washing, protein complexes were dissolved in 2 × SDS loading dye and then subjected to western blot.
Cellular localization studies
Cells cultured on cover slips were fixed with 4% paraformaldehyde and permeabilized by pre-chilled acetone and methanol (1:3). After blocking with 3% bovine serum albumin followed by primary antibodies at 4°C overnight, fluorescent labeled secondary antibodies were added and incubated at room temperature for 1 h. After thorough washing, cover slips were mounted on glass slide using DAPI (4,6-diamidino-2-phenylindole). Fluorescent images were captured by fluorescence microscope (Model IX81; Olympus, Valley Point, Singapore) or by confocal microscope (Model -NLO710; Carl Zeiss, Oberkochen, Germany).
Cell adhesion and migration assay
Cell adhesion assay was carried out in 24-well plates (Corning) coated with fibronectin 5 μg/ml (Sigma-Aldrich) as described previously. 39 Wound closure assays were carried out to determine cell migration as described previously. 24 FA disassembly assay FA disassembly assay was performed as described previously. 20 Cells grown on fibronectin-coated glass cover slips were serum starved for 48 h and then treated with 10 μM nocodazole for 4 h. Post treatment, drug was removed and cells were allowed to resume the polymerization of microtubules for various time points in growth medium. Cells were then fixed in 4% paraformaldehyde and images were captured by DeltaVision Elite deconvolution microscope (GE Healthcare, Pittsburgh, PA, USA).
Live-cell time-lapse microscopy and quantification of adhesion dynamics
Cells were cotransfected with control sh or HPIP sh1 and DsRed-zyxin using Lipofectamine 2000 (New York, NY, USA). After 48 h of transfection, the dynamics of DsRed-zyxin at FA points was monitored for 60 min using 100 × objectives on a fluorescence microscope. When necessary, F14 (Santa Cruz Biotechnology), a FAK-specific inhibitor, was used at concentrations of 10 μM for 6 h. Quantification of adhesion dynamics was performed as described previously. 41, 42 Rate constant measurements for disassembly (decreasing fluorescence intensity) of individual adhesions were determined from the slopes of trend lines fitted to semilogarithmic plots of fluorescence intensity ratios over time as described previously. 42 FA area was calculated using the formula πd 2 /4 × l (d = width, l = length), from randomly selected 15-20 FAs from 7 to 10 different cells.
In vivo phosphorylation
For in vivo phosphorylation, cells incubated in phosphate-free Dulbecco's modified Eagle's medium medium for 12 h in the presence of 250 μCi of [ 32 P]orthophosphoric acid/ml were collected in RIPA lysis buffer. After immunoprecipitation of the cell lysates using calpain2 antibody, samples were resolved by SDS-PAGE, transferred onto nitrocellulose membrane and subjected to autoradiography.
In vitro calpain cleavage assay
Calpain cleavage assay was performed as described previously. 41 Immunoprecipitated GFP-HPIP from HEK293T cells was incubated in cleavage buffer (50 mM Tris-HCl, pH 7.4, 137 mM KCl and 1 mM MgCl 2 ) at different concentrations of purified calpain2 (Calbiochem, San Diego, CA, USA) at 30°C for 30 min in the absence or presence of CaCl 2 (1 mM). Cleavage reactions were stopped by the addition of 4 × SDS sample buffer and reaction mixtures were subjected to SDS-PAGE followed by western blot.
Immunohistochemistry
Resected specimens from human breast tumors were fixed with 10% paraformaldehyde and embedded in paraffin blocks. After rehydration, 5 μM sections of representative tumor blocks were subjected to antigen retrieval in boiling buffer (10 mM sodium citrate and 10 mM citric acid) for 10 min. Sections were then treated with protein-blocking solution for 30 min and incubated with HPIP antibody (1:100; Bethyl laboratories, Montgomery, TX, USA) for overnight at 4°C. After several rinses in phosphate-buffered saline, the sections were incubated in biotinylated secondary antibody for 30 min. The bound antibodies were detected using Vecta Elite ABC staining kit (Vector Laboratories, Burlingame, CA, USA). The slides were rinsed in phosphate-buffered saline, exposed to diaminobenzidine and counterstained with Mayer's hematoxylin. Expression of HPIP was measured depending on the intensity of immunoreactivity and scored as mild (+), moderate (++) and intense (+++).
Bioinformatics and statistical analysis
Oncomine, a publicly available cancer database (Compendia Biosciences, Ann Arbor, MI, USA), was used for gene expression analysis. To analyze HPIP expression in cancer samples, several breast cancer data sets were exported from Oncomine. Box plot was used to show fold change of HPIP expression in invasive breast carcinomas vs normal tissues. For clinical data set survival analysis, association between HPIP expression and breast cancer patient survival was assessed by Kaplan-Meier plotter (www. kmplot.com/breast). 27 For reproducibility, all the experiments were performed two to three times. The results are expressed as means ± s.d., and differences between groups were analyzed by one-way analysis of variance using sigma plot.
